Cargando…

Using BERT to identify drug-target interactions from whole PubMed

BACKGROUND: Drug-target interactions (DTIs) are critical for drug repurposing and elucidation of drug mechanisms, and are manually curated by large databases, such as ChEMBL, BindingDB, DrugBank and DrugTargetCommons. However, the number of curated articles likely constitutes only a fraction of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldahdooh, Jehad, Vähä-Koskela, Markus, Tang, Jing, Tanoli, Ziaurrehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214985/
https://www.ncbi.nlm.nih.gov/pubmed/35729494
http://dx.doi.org/10.1186/s12859-022-04768-x
_version_ 1784731117544275968
author Aldahdooh, Jehad
Vähä-Koskela, Markus
Tang, Jing
Tanoli, Ziaurrehman
author_facet Aldahdooh, Jehad
Vähä-Koskela, Markus
Tang, Jing
Tanoli, Ziaurrehman
author_sort Aldahdooh, Jehad
collection PubMed
description BACKGROUND: Drug-target interactions (DTIs) are critical for drug repurposing and elucidation of drug mechanisms, and are manually curated by large databases, such as ChEMBL, BindingDB, DrugBank and DrugTargetCommons. However, the number of curated articles likely constitutes only a fraction of all the articles that contain experimentally determined DTIs. Finding such articles and extracting the experimental information is a challenging task, and there is a pressing need for systematic approaches to assist the curation of DTIs. To this end, we applied Bidirectional Encoder Representations from Transformers (BERT) to identify such articles. Because DTI data intimately depends on the type of assays used to generate it, we also aimed to incorporate functions to predict the assay format. RESULTS: Our novel method identified 0.6 million articles (along with drug and protein information) which are not previously included in public DTI databases. Using 10-fold cross-validation, we obtained ~ 99% accuracy for identifying articles containing quantitative drug-target profiles. The F1 micro for the prediction of assay format is 88%, which leaves room for improvement in future studies. CONCLUSION: The BERT model in this study is robust and the proposed pipeline can be used to identify previously overlooked articles containing quantitative DTIs. Overall, our method provides a significant advancement in machine-assisted DTI extraction and curation. We expect it to be a useful addition to drug mechanism discovery and repurposing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04768-x.
format Online
Article
Text
id pubmed-9214985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92149852022-06-23 Using BERT to identify drug-target interactions from whole PubMed Aldahdooh, Jehad Vähä-Koskela, Markus Tang, Jing Tanoli, Ziaurrehman BMC Bioinformatics Research BACKGROUND: Drug-target interactions (DTIs) are critical for drug repurposing and elucidation of drug mechanisms, and are manually curated by large databases, such as ChEMBL, BindingDB, DrugBank and DrugTargetCommons. However, the number of curated articles likely constitutes only a fraction of all the articles that contain experimentally determined DTIs. Finding such articles and extracting the experimental information is a challenging task, and there is a pressing need for systematic approaches to assist the curation of DTIs. To this end, we applied Bidirectional Encoder Representations from Transformers (BERT) to identify such articles. Because DTI data intimately depends on the type of assays used to generate it, we also aimed to incorporate functions to predict the assay format. RESULTS: Our novel method identified 0.6 million articles (along with drug and protein information) which are not previously included in public DTI databases. Using 10-fold cross-validation, we obtained ~ 99% accuracy for identifying articles containing quantitative drug-target profiles. The F1 micro for the prediction of assay format is 88%, which leaves room for improvement in future studies. CONCLUSION: The BERT model in this study is robust and the proposed pipeline can be used to identify previously overlooked articles containing quantitative DTIs. Overall, our method provides a significant advancement in machine-assisted DTI extraction and curation. We expect it to be a useful addition to drug mechanism discovery and repurposing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04768-x. BioMed Central 2022-06-21 /pmc/articles/PMC9214985/ /pubmed/35729494 http://dx.doi.org/10.1186/s12859-022-04768-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aldahdooh, Jehad
Vähä-Koskela, Markus
Tang, Jing
Tanoli, Ziaurrehman
Using BERT to identify drug-target interactions from whole PubMed
title Using BERT to identify drug-target interactions from whole PubMed
title_full Using BERT to identify drug-target interactions from whole PubMed
title_fullStr Using BERT to identify drug-target interactions from whole PubMed
title_full_unstemmed Using BERT to identify drug-target interactions from whole PubMed
title_short Using BERT to identify drug-target interactions from whole PubMed
title_sort using bert to identify drug-target interactions from whole pubmed
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214985/
https://www.ncbi.nlm.nih.gov/pubmed/35729494
http://dx.doi.org/10.1186/s12859-022-04768-x
work_keys_str_mv AT aldahdoohjehad usingberttoidentifydrugtargetinteractionsfromwholepubmed
AT vahakoskelamarkus usingberttoidentifydrugtargetinteractionsfromwholepubmed
AT tangjing usingberttoidentifydrugtargetinteractionsfromwholepubmed
AT tanoliziaurrehman usingberttoidentifydrugtargetinteractionsfromwholepubmed